• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Puma Biotechnology, Inc. (PBYI)

    -NYSE
    221.30 Up 12.64(6.06%) Dec 19, 4:01PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development32,092  35,001  16,294  13,006  
    Selling General and Administrative3,867  3,904  3,525  2,983  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (35,959) (38,905) (19,819) (15,989)
    Income from Continuing Operations
    Total Other Income/Expenses Net115  61  25  43  
    Earnings Before Interest And Taxes(35,844)(38,844)(19,794)(15,946)
    Interest Expense -   -   -   -  
    Income Before Tax(35,844)(38,844)(19,794)(15,946)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(35,844)(38,844)(19,794)(15,946)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (35,844) (38,844) (19,794) (15,946)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (35,844) (38,844) (19,794) (15,946)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.